Literature DB >> 25617594

The joint influence of acquired capability for suicide and stoicism on over-exercise among women.

April R Smith1, Aimee E Yeager2, Dorian R Dodd2.   

Abstract

We investigated longitudinal relationships among eating disorder behaviors, stoicism, and the acquired capability for suicide (ACS), which is a construct comprised of pain tolerance and fearlessness about death. University students (n=150) completed assessments measuring stoicism, ACS, and eating disorder behaviors at two time points approximately 30days apart. Among women, there was a quadratic relationship between ACS and over-exercise behaviors, such that as ACS increased the positive association between ACS and over-exercise became more pronounced. Further, among women, ACS moderated the relationship between stoicism and over-exercise, such that high levels of ACS in combination with stoicism predicted increases in over-exercise. Results suggest that ACS in combination with stoicism may lead women to engage in more eating disordered behaviors, like over-exercise.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acquired capability for suicide; Eating disorders; Interpersonal theory of suicide; Over-exercise; Stoicism

Mesh:

Year:  2014        PMID: 25617594     DOI: 10.1016/j.eatbeh.2014.12.010

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  2 in total

1.  Is childhood trauma associated with lifetime suicide attempts in women with bulimia nervosa?

Authors:  Christina E Smith; Emily M Pisetsky; Stephen A Wonderlich; Ross D Crosby; James E Mitchell; Thomas E Joiner; Anna Bardone-Cone; Daniel Le Grange; Marjorie H Klein; Scott J Crow; Carol B Peterson
Journal:  Eat Weight Disord       Date:  2015-10-13       Impact factor: 4.652

2.  Stoic beliefs and health: development and preliminary validation of the Pathak-Wieten Stoicism Ideology Scale.

Authors:  Elizabeth B Pathak; Sarah E Wieten; Christopher W Wheldon
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.